In a recent study published in Scientific Reports, researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and severe acute respiratory syndrome coronavirus 2 ...

A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors Adoptive immunotherapy using tumor-infiltrating lymphocytes ...

Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient's own tumors, could provide ...

Please provide your email address to receive an email when new articles are posted on . At baseline, patients with JIA had higher C-reactive protein and CRP-to-albumin ratio vs. controls. C-reactive ...

Vaccination efforts worldwide have drastically diminished morbidity and mortality rates for many infectious diseases, with some pathogens being entirely eradicated. However, to optimize long-term ...

In a recent study, immune-inflammatory index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were associated with infection of respiratory syncytial virus (RSV) in children. High ...

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to ...

A small trial by investigators at the National Cancer Institute holds promise to bring personalized cell therapy into the solid tumor arena, after more than a decade of success in blood cancers. A new ...